Polar Capital Funds PLC - Biotechnology Fund I IncRegistrer dig for at låse op for ratings |
Fondens performance | 31-03-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | 28,7 | 12,5 | -1,1 | 12,2 | 9,7 | |
+/-Kat | 9,9 | 15,6 | 11,7 | 10,9 | 5,9 | |
+/-Indeks | 3,4 | 5,7 | 2,0 | 2,1 | -0,4 | |
Kategori: Sektor - Bioteknologi, Aktier | ||||||
Kategoribenchmark: Morningstar Gbl Biotechnolo... |
Oversigt | ||
Seneste NAV 18-04-2024 | USD 42,96 | |
Kursændring 1 dag | -0,96% | |
Morningstar Kategori™ | Sektor - Bioteknologi, Aktier | |
ISIN | IE00B42Z4531 | |
Markedsværdi i alt (mio.) 18-04-2024 | USD 1624,60 | |
Seneste TNA(mio.) 18-04-2024 | USD 949,34 | |
Emissionstillæg | 5,00% | |
Løbende omkostning 31-12-2023 | 1,12% | |
Performance omkostning | 10,00% | |
Investeringsstrategi | Aktiv |
Investeringsmålsætning: Polar Capital Funds PLC - Biotechnology Fund I Inc |
The investment objective of the Fund is to preserve capital and achieve long term capital appreciation. |
Returns | ||||||||||||||||
|
Management | ||
Manager navn Startdato | ||
David Pinniger 31-10-2013 | ||
Gareth Powell 31-10-2013 | ||
Startdato 31-10-2013 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
NASDAQ Biotechnology NR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Formuefordeling Polar Capital Funds PLC - Biotechnology Fund I Inc | 29-02-2024 |
|
|
Top 5 placeringer | Sektor | % |
Regeneron Pharmaceuticals Inc | Healthcare | 6,59 |
Zealand Pharma A/S | Healthcare | 5,48 |
Celldex Therapeutics Inc | Healthcare | 4,78 |
argenx SE | Healthcare | 4,75 |
Blueprint Medicines Corp | Healthcare | 4,39 |
Øget Mindsket Ny siden sidste portefølje | ||
Polar Capital Funds PLC - Biotechnology Fund I Inc |